Submission to first decision
35 days

CNS Drugs promotes rational pharmacotherapy within the disciplines of clinical psychiatry and neurology. The Journal includes:
Overviews of contentious or emerging issues.
Comprehensive narrative reviews that provide an authoritative source of information on pharmacological approaches to managing neurological and psychiatric illnesses.
Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in neurology and psychiatry.
Original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.
Additional enhanced features (including slide sets, videos and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in CNS Drugs may be accompanied by plain language summaries to assist readers in understanding important medical advances.
All manuscripts are subject to peer review by international experts. Letters to the Editor are welcomed and will be considered for publication.

Editors (Adis International Limited, Auckland, New Zealand):
Kate Palmer
Sue Pochon
Section Editors (Adis International Limited, Auckland, New Zealand):
Martin Chopra
Alison Fitches
Dene Peters
Amitabh Prakash
Editorial Board:
D.S. Baldwin, University of Southampton, Southampton, England
R.L. Barkin, North Shore University Health System (Anesthesiology) and Rush University, Chicago, IL, USA
T.R.E. Barnes, Imperial College London, London, England
M. Berk, Deakin University, Geelong, VIC, Australia
M. Bialer, The Hebrew University of Jerusalem, Jerusalem, Israel
J. Biller, Loyola University Chicago, Maywood, IL, USA
H. Brodaty, Prince of Wales Hospital, Randwick, NSW, Australia
M.J. Brodie, West Glasgow Ambulatory Care Hospital, Glasgow, Scotland
M.J. Carpenter, Medical University of South Carolina, Charleston, SC, USA
M.C. Chamberlain, University of Washington, Seattle, WA, USA
D.R. Coghill, University of Melbourne, Melbourne, VIC, Australia
S. Cortese, University of Southampton, Southampton, England
M.J. Eadie, University of Queensland, Brisbane, QLD, Australia
M.R. Farlow, Indiana University School of Medicine, Indianapolis, IN, USA
G.A. Fava, University of Bologna, Bologna, Italy
S.H. Fox, University Health Network, Toronto, ON, Canada
G.T. Grossberg, St Louis University School of Medicine, St. Louis, MO, USA
D. Gurwitz, Tel-Aviv University, Tel Aviv, Israel
M. Hahn, Vitos Klinik, Eltville, Germany
G. Hajak, University of Regensburg, Regensburg, Germany
H-P. Hartung, Heinrich-Heine-University, Duesseldorf, Germany
M.W. Jann, University of North Texas, Fort Worth, TX, USA
D. Kemp, Case Western Reserve University, Cleveland, OH, USA
S.G. Kornstein, Virginia Commonwealth University, Richmond, VA, USA
P. Kwan, University of Melbourne, Royal Melbourne Hospital, Parkville, VIC, Australia
R.W. Lam, University of British Columbia, Vancouver, BC, Canada
L. Leggio, NIAAA and NIDA, NIH, Bethesda, MD, USA
B.E. Leonard, National University of Ireland, Galway, Ireland
P. Mitchell, University of New South Wales, Randwick, NSW, Australia
J.H. Newcorn, Icahn School of Medicine at Mount Sinai, New York, NY, USA
E. Perucca, University of Pavia, Pavia, Italy
R.M. Post, George Washington University, Washington DC and Bipolar Collaborative Network, Washington DC, USA
S.K. Praharaj, Kasturba Medical College, Manipal, Karnataka, India
A.M. Rapoport, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA
O. Rascol, University Hospital, Toulouse, France
D.A. Revicki, Evidera, Bethesda, MD, USA
K.L. Roos, Indiana University Hospital, Indianapolis, IN, USA
J.F. Rosenbaum, Massachusetts General Hospital, Boston, MA, USA
M.V. Rudorfer, National Institute of Mental Health, Bethesda, MD, USA
S.C. Schachter, Beth Israel Deaconess Medical Center, Boston, MA, USA
S.A. Schug, Royal Perth Hospital, Perth, WA, Australia
S. Seedat, Stellenbosch University, Cape Town, South Africa
S.D. Silberstein, Thomas Jefferson University Hospital, Philadelphia, PA, USA
D. Taylor, Maudsley Hospital, London, England
C. Trenkwalder, Paracelsus-Elena Hospital, Kassel, Germany
E. Trinka, Paracelsus Medical University Salzburg, Salzburg, Austria
B. Vitiello, University of Turin, Turin, Italy
B. Weinstock-Guttman, State University of New York, Buffalo, NY, USA
J.W. Winkelman, Harvard Medical School, Boston, MA, USA
I.C.K. Wong, University of Hong Kong, Hong Kong
J. Zajecka, Rush University Medical Center, Chicago, IL, USA